Within3, a Cleveland, OH-based provider of digital collaboration solutions for the pharmaceutical and life sciences industries, has secured a new round of equity financing.
The investment, which brings the company’s aggregate funding to $20m, was led by Easton Capital.
Within3 intends to use the capital to continue to expand its customer base and supporting infrastructure.
Led by Lance Hill, CEO, Within3 builds private, regulatory-compliant digital collaboration programs for pharmaceutical companies and other life sciences institutions to efficiently engage with groups of health professionals from around the world. Clients includes ten of the Top 20 pharmaceutical companies, mid-tier pharmaceutical companies, medical associations and hospitals, as well as large and boutique medical communications companies.